<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药合作投融资联盟 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-16T11:25:14+08:00</updated>
  <subtitle>医药行业</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>合作进展| 复星医药引进的mRNA疫苗国内进入II期临床</title>
    <updated>2020-11-16T10:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/OXT38_ROZeINRYNZlHDHVw</id>
    <link href="https://mp.weixin.qq.com/s/OXT38_ROZeINRYNZlHDHVw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Robert Langer参与创立的又一家公司提交IPO上市申请</title>
    <updated>2020-11-16T10:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/g30mNsC9Qj07zJkSZspC-A</id>
    <link href="https://mp.weixin.qq.com/s/g30mNsC9Qj07zJkSZspC-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州合作伙伴BioAtla提交上市申请，拟募资1亿美元</title>
    <updated>2020-11-16T10:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/e6is0GyqGOvN2SbEtRIieA</id>
    <link href="https://mp.weixin.qq.com/s/e6is0GyqGOvN2SbEtRIieA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三轮融资近2亿美元，这家临床前肿瘤小分子公司提交IPO上市申请</title>
    <updated>2020-11-16T10:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/DqUVwb8Yu53cz4yd6mandg</id>
    <link href="https://mp.weixin.qq.com/s/DqUVwb8Yu53cz4yd6mandg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>补体新药！科越医药完成4600万美元融资，走出隐匿模式</title>
    <updated>2020-11-13T08:18:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/VHxqJ7N09zkJirRGi0c-6w</id>
    <link href="https://mp.weixin.qq.com/s/VHxqJ7N09zkJirRGi0c-6w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基石药业宣布NMPA已受理PD-L1单抗舒格利单抗上市申请</title>
    <updated>2020-11-13T08:18:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/gKfp-SvbFyIbPYean00UQA</id>
    <link href="https://mp.weixin.qq.com/s/gKfp-SvbFyIbPYean00UQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复宏汉霖CD38抗体HLX15提交临床申请，研发投入约1511万元</title>
    <updated>2020-11-13T08:18:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/PrM2zN_MaZlAaEZOl4RbNw</id>
    <link href="https://mp.weixin.qq.com/s/PrM2zN_MaZlAaEZOl4RbNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>昆药集团IDH1抑制剂获批临床，研发投入约2569万元</title>
    <updated>2020-11-13T08:18:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/mAb5AR1GqnEEttnG6fQplw</id>
    <link href="https://mp.weixin.qq.com/s/mAb5AR1GqnEEttnG6fQplw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下一代基因编辑公司Metagenomi完成6500万美元A轮融资</title>
    <updated>2020-11-13T08:18:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/nxWHTu12vzaracOQGCipeA</id>
    <link href="https://mp.weixin.qq.com/s/nxWHTu12vzaracOQGCipeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向内源性大麻素Synendos完成2000万瑞士法郎A轮融资</title>
    <updated>2020-11-13T08:18:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/Aj6Dm2OhZ5j02UjUOsg_Vg</id>
    <link href="https://mp.weixin.qq.com/s/Aj6Dm2OhZ5j02UjUOsg_Vg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Inipharm完成A轮3500万美元融资，专注于高度验证的遗传靶标</title>
    <updated>2020-11-13T08:18:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/B-PLnTn1VCqQzUcqDMoINQ</id>
    <link href="https://mp.weixin.qq.com/s/B-PLnTn1VCqQzUcqDMoINQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>标新生物完成数千万天使轮融资，超10亿元引进PROTAD分子</title>
    <updated>2020-11-13T08:18:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/7lV3eh7tAQzJnKFv9T3Qgw</id>
    <link href="https://mp.weixin.qq.com/s/7lV3eh7tAQzJnKFv9T3Qgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！费米子科技完成A轮融资，累计融资额上亿元</title>
    <updated>2020-11-12T07:45:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/V3cp5v0_6otoS1LXeErNuw</id>
    <link href="https://mp.weixin.qq.com/s/V3cp5v0_6otoS1LXeErNuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅 | 晶泰科技与华东医药签署又一抗肿瘤新药研发协议！</title>
    <updated>2020-11-12T07:45:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/X0hWjjq9T2GbqjlNKJ5rsw</id>
    <link href="https://mp.weixin.qq.com/s/X0hWjjq9T2GbqjlNKJ5rsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BD交易|诺迪康药业900万美元引进俄罗斯已上市新冠疫苗</title>
    <updated>2020-11-12T07:45:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/cHXnigJYUiYUzIn-gUgzNg</id>
    <link href="https://mp.weixin.qq.com/s/cHXnigJYUiYUzIn-gUgzNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>细胞治疗公司CoImmune完成4500万美元A轮融资</title>
    <updated>2020-11-12T07:45:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/iGDNcrENaOYrTIvQ8Aa3sw</id>
    <link href="https://mp.weixin.qq.com/s/iGDNcrENaOYrTIvQ8Aa3sw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>AI前沿！Trailhead Biosystems完成660万美元A轮融资</title>
    <updated>2020-11-12T07:45:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/QUMjnvsJiPwjNpMiJlr_ow</id>
    <link href="https://mp.weixin.qq.com/s/QUMjnvsJiPwjNpMiJlr_ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧康维视启动0T-301第二个III期临床试验</title>
    <updated>2020-11-12T07:45:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/X4ZpKx-P3UOQxnjOTnMT2g</id>
    <link href="https://mp.weixin.qq.com/s/X4ZpKx-P3UOQxnjOTnMT2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康方生物公布其二代CD47抗体临床数据，与天境、信达同台PK</title>
    <updated>2020-11-12T07:45:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/3K_m3shT6iGfZ8ms0BvwIg</id>
    <link href="https://mp.weixin.qq.com/s/3K_m3shT6iGfZ8ms0BvwIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药PD-L1/TGF-β抗体韩国权益以229万美元首付款授权给韩国东亚公司</title>
    <updated>2020-11-11T09:59:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/-bkekiFP4dL6E5JvFMI3fg</id>
    <link href="https://mp.weixin.qq.com/s/-bkekiFP4dL6E5JvFMI3fg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>